Study on the expression of serum sST2 and its relationship with disease severity in patients with chronic hepatitis B
Lan-yi LIN,Shao-wen JIANG,Rui-dong MO,Xiao-gang XIANG,Rong-tao LAI,Hui WANG,Gang-de ZHAO,Wei CAI,Qing GUO,Bei XU,Qing XIE
DOI: https://doi.org/10.14000/j.cnki.issn.1008-1704.2017.11.006
2017-01-01
Abstract:Objective To investigate the role of interleukin-33/ST2 expression in the progression of liver fibrosis,and its relationship with disease severity in patients with chronic hepatitis B (CHB).Methods A total of 105 patients from January 2013 to December 2016 in Ruijin hospital were enrolled,containing 46 patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (HBV-ACLF) and 59 patients with CHB.Patients in CHB group all underwent liver biopsy,and were divided into F0-2 (non or mild fibrosis) subgroup (n =12),F3-4 (moderate fibrosis) subgroup (n =12),F5 (advanced fibrosis) subgroup (n =12) and F6 (liver cirrhosis) subgroup (n =23) according to Ishak scoring system.Twenty healthy volunteers were enrolled as controls.Serum levels of IL-33 and sST2 of all participants were detected using enzyme linked immunosorbent assay (ELISA),and the relationship between progression of liver fibrosis and disease severity was analyzed.Results Serum sST2 level in F6 subgroup (21.3 ± 4.7 ng/mL) were significantly higher than that in F5,F3-4,F0-2 and control group (5.1 ± 0.8 ng/mL,5.6 ± 0.8 ng/mL,3.8 ± 0.4 ng/mL and 6.9 ± 0.7 ng/mL,all P＜0.05),respectively,but was notably lower than that in HBV-ACLF group (63.5± 3.9,P＜0.001).In all patients,serum levels of sST2 were positively correlated with aspartate aminotransferase (AST) and total bilirubin (TBil) (both P＜0.05),but negatively correlated with albumin level and platelet counts (both P＜0.001).However,there was no correlation between serum sST2 and ALT levels.The serum levels of IL-33 were 4.7 ± 1.0 pg/mL,4.2 ± 0.7 pg/mL,4.1 ± 1.1 pg/mL,5.4 ± 2.0 pg/mL,5.5 ± 0.9 pg/mL and 5.4 ± 0.5 pg/mL in F6,F5,F3-4,F0-2,HC and HBV-ACLF group,respectively,with no statistical significance among these groups.Conclusion Serum sST2,other than serum IL-33,was associated with the progression of liver fibrosis and disease severity in CHB patients.